Pentostatin, Cyclophosphamide, and Rituximab Followed By Alemtuzumab in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
This study is currently recruiting participants.
Study NCT00074282
Information provided by National Cancer Institute (NCI)
First Received: December 10, 2003
Last Updated: November 17, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
